Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$322,436,353
+$63,831,674 QoQ
Shares Held
2,057,404
+21.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. NVS ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,436,353 | 2,057,404 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $258,604,679 | 1,692,993 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $229,180,747 | 1,662,296 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $205,150,271 | 1,599,737 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $186,471,931 | 1,540,963 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $163,542,942 | 1,467,016 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $128,201,836 | 1,317,458 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $155,669,447 | 1,353,412 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $136,598,611 | 1,283,098 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $117,231,438 | 1,211,945 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $120,974,376 | 1,198,122 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $124,431,054 | 1,221,589 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $119,610,638 | 1,185,320 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $102,047,044 | 1,109,207 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $116,371,712 | 1,282,757 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $109,131,432 | 1,435,751 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $119,416,966 | 1,412,717 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $117,811,481 | 1,342,581 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $103,229,731 | 1,180,173 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $90,646,586 | 1,108,420 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $115,528,361 | 1,266,203 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $99,504,874 | 1,164,072 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $124,281,399 | 1,316,122 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $103,999,028 | 1,195,941 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $86,620,404 | 991,761 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $111,497,133 | 1,352,300 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||